Home / Private raises / Vesalius Longevity Labs Inc.

Vesalius Longevity Labs Inc.

Pharmaceuticals · Vancouver, British Columbia, Canada · $36.6M sold across 2 offerings

Form D filings (2)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-11-18D (new)$6.5M$13.5M9506(b)Equity, Options/warrants, Security to be acquiredNov 6SEC ↗
2026-11-03D (new)$30.1M$30.1M62506(b)EquityOct 28SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Issuer

IndustryPharmaceuticals
LocatedVancouver, British Columbia, Canada
EntityCorporation
IncorporatedBritish Columbia, Canada
SEC CIK2131865

People named in the latest filing

NameRole
Christopher CooperChief Financial Officer
Kevin SerreDirector
Robert McCueDirector
Joel LeonoffDirector
Kevin MayerDirector
Lee ApplbaumDirector
David AdelmanDirector
Timmi StumpExecutive Officer
Pradeep AlbertChief Executive Officer
James McRobertsDirector

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?